In conclusion, we have developed a new breast cancer subtyping method called PCA-PAM50, which couples the conventional PAM50 method with PCA for selection of a gene expression–based ER-balanced subset as the first step for intrinsic subtyping. This evidence concerns the gene ESR1 and breast cancer.